Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 5 composition records across product categories including Laboratory supplies, Personal care.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of HISTIDINE in our catalog (fda_ndc).
Products
59
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside HISTIDINE in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 5 composition records across product categories including Laboratory supplies, Personal care. EPA CPDat classifies this chemical for functional uses including Humectant, Anti-static agent, Softener and conditioner.
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTABLE, LIPOSOMAL; Maximum daily exposure: 63 mg
US
FDA
Coconut Milk
Herbal Essences
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 465 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.09 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Potency: 0.16 %w/v
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Potency: 5 mg/1ml
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 3.88 mg
US
FDA
FDA NDC lists this ingredient in 59 active drug products and 59 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.